China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets

Published: October2011
No. of Pages: 167
Price: $ 3500


China’s rapid economic development and numerous steps of reform undertaken by the Chinese central government since 1997 had clear and observable effects upon China’s total healthcare services market and product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, including increased funding, to improve services.

What are the workings of China's healthcare system? How much progress has been made towards the promised vision of the CPCC in 2008 to provide "convenient and affordable access" to its people? What are the effects on foreign companies seeking to benefit from an increase in healthcare-related funding? Where are the best opportunities in China for marketers. Analyst Emil Salazar focuses on these questions.

The report China Healthcare Reform Impact contains a comprehensive overview of the Chinese healthcare system with important data for marketers to China. It discusses healthcare reform plans and where funds were spent. It also describes the role foreign companies play. As part of its analysis, the report includes the following information:
• Statistics on Chinese Hospitals, Community Health Centers and Clinics
• Top and Bottom City Markets for Urban Healthcare
• Top and Bottom Rural Regions
• Challenges for Foreign-Owned MNCs in China
• Government Healthcare Spending
• Foreign-Invested Manufacturing Enterprises in China
• Share of Government Funded Healthcare vs. Out of Pocket
• Domestic Healthcare Industries
• Population and Age Statistics
• Incidence Rates for Infectious Diseases
• Cancer Rates in China
• Regulation of Drugs and Devices in China
• U.S. Product Exports to China
• Key Analyst Conclusions

In addition to providing useful background information and a thorough analysis of China's healthcare changes, the report China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets provides data for business planning. The report also takes a look at the status and forecast of the three key healthcare markets in China:
• The Chinese Market for IVD products
• Regional Breakout of Chinese IVD Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• The Chinese Market for Medical Device Products
• Regional Breakout of Chinese Medical Device Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of Chinese Medical Device Market(Surgical Instrument, Disposable, Patient Monitoring, IVD, Imaging, Orthopedic, Other)
• The Chinese Market for Pharmaceutical Products
• Regional Breakout of Pharmaceutical Market(Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of Pharmaceutical Market (Cardiovascular, Gastrointestinal, Anti-Infectives, Neurotherapeutics, Oncology, Respiratory, Other)
This essential resource for anyone marketing a healthcare product to China was constructed using a combination of primary and secondary sources. Corporate reports, trade publications government information and medical journals, previous market research studies conducted by Kalorama and other sources were used. In some cases, interviews were used to determine forecasts and key trends.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

U.S. Market for Dental Prosthetics and CAD/CAM Devices 2011

Published: October 2011
No. of Pages: 275
Price: $ 7495


In 2010, the U.S. market for dental prosthetics, which includes crowns, bridges, inlays/onlays, veneers and dentures, exceeded $11 billion. The market has recovered from the slowdown caused by the economic recession of 2008 and 2009. Lingering effects of the recession continued to affect various segments of the market adversely; however, the prosthetics market is expected to continue to grow as the number of patients requiring dental prosthetics increases.

Browse All: Medical Devices Market Research 


The market segments covered in this report U.S. Market for Dental Prosthetics and CAD/CAM Devices 2011 include:
• Crowns and Bridges
• Inlays and onlays
• Veneers
• Dentures
• CAD/CAM Systems
• CAD/CAM Blocks and Prosthetic Devices
• Intra-Oral Digital Impression-Taking Systems
• Automated Prosthetics Manufacturing
• Rapid Prototyping Systems/3D Printing

Within the dental prosthetics market, companies such as Dental Services Group, Glidewell Laboratories and National Dentex Corporation lead the market. Within the CAD/CAM System market companies such as 3M, DENSPLY and Sirona lead the market. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition

Published: October 2011

No. of Pages: 155

Price: $ 3500

Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects.

Growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market. Biological products are developed from large and complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. Protein-based biopharmaceuticals are invariably produced by an initial cell culture step (upstream processing), followed by product recovery, purification and formulation into final product format (downstream processing).

This report analyzes the world market for the cell cultures used in these steps and the major trends driving this market. Forecasts and current market sizing are provided in three specific segments:

• Media,

• Sera, and

• Reagents

Browse All: Biotechnology Market Research Reports

In addition to a thorough discussion of the technologies and techniques currently employed and emerging in the cell culture area, the Kalorama's exhaustive report provides specific information on:

• Market Size, growth, and forecasts of the segments through 2015

• Competitive Market Share by leading supplier as of 2010.

• Estimated Market Share by Region (North America, Europe, U.S.)

• Key Market Drivers and Restraints for suppliers, including discussions of biopharmaceutical pipelines, biomedical R&D directions, and the future of transgenic plant and animal production.

• Review of the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems

• Discussion of the preferences in media types vying for dominance in the market, including the following:

ADCF - animal derived component free media

CD - chemically defined media

CSFM - complete serum free medium

PF - protein free media

SF - serum free media

SFM - serum free medium

• Major Trends Impacting the Market stem cell research (including plans of major companies)cell culture-based vaccine Production and generic bipharmaceuticals

• Profiles of Leading Suppliers and information about M&A activities in recent years

The information for this report Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company and cell culture supply company representatives included marketing directors, division managers, and product representatives.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.